Xanthohumol microbiome and signature in adults with Crohn’s disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial

被引：0
作者：
Blake O. Langley
Jennifer Joan Ryan
John Phipps
Lita Buttolph
Brenna Bray
Joseph E. Aslan
Thomas O. Metz
Jan F. Stevens
Ryan Bradley
机构：
[1] Helfgott Research Institute,School of Nursing
[2] National University of Natural Medicine (NUNM),School of Medicine
[3] University of Washington,Biological Sciences Division
[4] Oregon Health and Science University,College of Pharmacy and the Linus Pauling Institute
[5] Pacific Northwest National Laboratory,Herbert Wertheim School of Public Health and Human Longevity Science
[6] Oregon State University,undefined
[7] University of California,undefined
[8] San Diego,undefined
来源：
Trials | / 23卷
关键词：
Natural product; Xanthohumol; Crohn’s disease; Inflammatory bowel disease; Microbiome; Inflammation; Safety; Tolerability; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
    Piette, Francois
    Belmin, Joel
    Vincent, Helene
    Schmidt, Nicolas
    Pariel, Sylvie
    Verny, Marc
    Marquis, Caroline
    Mely, Jean
    Hugonot-Diener, Laurence
    Kinet, Jean-Pierre
    Dubreuil, Patrice
    Moussy, Alain
    Hermine, Olivier
    ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (02)
  • [42] Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial
    Dubey, Anand Prakash
    Agarkhedkar, Sharad
    Chhatwal, Jugesh
    Narayan, Arun
    Ganguly, Satyabrata
    Wartel, T. Anh
    Bouckenooghe, Alain
    Menezes, Josemund
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (02) : 512 - 518
  • [43] Randomized, Double-Blind, Placebo-Controlled Trial of the Oral Interleukin-12/23 Inhibitor Apilimod Mesylate for Treatment of Active Crohn's Disease
    Sands, Bruce E.
    Jacobson, Eric W.
    Sylwestrowicz, Thomas
    Younes, Ziad
    Dryden, Gerald
    Fedorak, Richard
    Greenbloom, Susan
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (07) : 1209 - 1218
  • [44] Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial
    Xu, Rui-Hua
    Shen, Lin
    Wang, Ke-Ming
    Wu, Gang
    Shi, Chun-Mei
    Ding, Ke-Feng
    Lin, Li-Zhu
    Wang, Jin-Wan
    Xiong, Jian-Ping
    Wu, Chang-Ping
    Li, Jin
    Liu, Yun-Peng
    Wang, Dong
    Ba, Yi
    Feng, Jue-Ping
    Bai, Yu-Xian
    Bi, Jing-Wang
    Ma, Li-Wen
    Lei, Jian
    Yang, Qing
    Yu, Hao
    CHINESE JOURNAL OF CANCER, 2017, 36
  • [45] Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
    Vermeire, Severine
    Schreiber, Stefan
    Petryka, Robert
    Kuehbacher, Tanja
    Hebuterne, Xavier
    Roblin, Xavier
    Klopocka, Maria
    Goldis, Adrian
    Wisniewska-Jarosinska, Maria
    Baranovsky, Andrey
    Sike, Robert
    Stoyanova, Kremena
    Tasset, Chantal
    Van der Aa, Annegret
    Harrison, Pille
    LANCET, 2017, 389 (10066) : 266 - 275
  • [46] Wangbi granule as a combination therapy to achieve clinical deep remission in rheumatoid arthritis: protocol for a multicenter, triple-blind, randomised, placebo-controlled trial
    Wang, Jinping
    Wang, Zihan
    Lan, Tianyi
    Zhang, Liubo
    Li, Zhenbin
    Wang, Xinchang
    Zou, Qinghua
    Wang, Yuan
    Li, Yanqi
    Luo, Ruili
    Zhang, Nan
    Xu, Yuan
    Li, Mengtao
    Tao, Qingwen
    CHINESE MEDICINE, 2023, 18 (01)
  • [47] Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II
    Alfred Gugerell
    Ghazaleh Gouya-Lechner
    Helmut Hofbauer
    Maria Laggner
    Franz Trautinger
    Gabriele Almer
    Anja Peterbauer-Scherb
    Marcus Seibold
    Wolfram Hoetzenecker
    Christiane Dreschl
    Michael Mildner
    Hendrik Jan Ankersmit
    Trials, 22
  • [48] Wangbi granule as a combination therapy to achieve clinical deep remission in rheumatoid arthritis: protocol for a multicenter, triple-blind, randomised, placebo-controlled trial
    Jinping Wang
    Zihan Wang
    Tianyi Lan
    Liubo Zhang
    Zhenbin Li
    Xinchang Wang
    Qinghua Zou
    Yuan Wang
    Yanqi Li
    Ruili Luo
    Nan Zhang
    Yuan Xu
    Mengtao Li
    Qingwen Tao
    Chinese Medicine, 18
  • [49] The effectiveness of intratympanic injections with methylPREDnisolon versus placebo in the treatment of vertigo attacks in MENière's disease (PREDMEN trial): a study protocol for a phase-3 multicentre, double-blinded, randomised, placebo-controlled trial
    Boreel, Maud Martina Emilie
    van Esch, Babette
    Schermer, Tjard R.
    Mol, Berber M.
    van Benthem, Peter Paul
    Bruintjes, Tjasse D.
    BMJ OPEN, 2024, 14 (08):
  • [50] A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease
    Bjarnason, Ingvar
    Sission, Guy
    Hayee, Bu'Hussaine
    INFLAMMOPHARMACOLOGY, 2019, 27 (03) : 465 - 473
12345